Selecting the appropriate hurdles and endpoints for pentilludin, a novel antiaddiction pharmacotherapeutic targeting the receptor type protein tyrosine phosphatase d

HIGHLIGHTS

  • who: George R. Uhl from the University of Murcia, Spain have published the paper: Selecting the appropriate hurdles and endpoints for pentilludin, a novel antiaddiction pharmacotherapeutic targeting the receptor type protein tyrosine phosphatase D, in the Journal: (JOURNAL)
  • what: The authors provide several possible examples below. continue development by providing tax benefits and a period of exclusivity .

SUMMARY

    Urgent public health needs Development of safe and effective medications to aid prevention and treatment of stimulant, opioid and stimulant + opioid use disorders are urgent public health needs. There are no FDAapproved medications . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?